TB-500: What the Research Shows TB-500 is a synthetic peptide centered on the LKKTETQ actin-binding motif of Thymosin Beta-4 (T4), the major actin-sequestering protein in mammalian cells
New England Journal of Medicine (2025) The REDEFINE 2 Phase 3 trial evaluated CagriSema in 1,206 adults with overweight or obesity and type 2 diabetes in a 68-week, double-blind, placebo-controlled design
Effects of long-term treatment with Acetyl-L-Carnitine
Needle aversion is real: about 10 percent of people have a serious phobia of needles, and between 3.5 and 10 percent of the general population may lose consciousness during needle procedures
This distribution pattern means AOD-9604 exerts its strongest effects precisely where intended (adipose tissue) with minimal effects elsewhere
If more than 3 days have passed, dose immediately regardless of meal timing to restore plasma levels, then resume your normal weekly schedule